<DOC>
	<DOCNO>NCT01665001</DOCNO>
	<brief_summary>The primary goal study The Polish Adult Leukemia Group ( PALG ) verify individual therapeutic approach take account biological phenotypic difference well response level minimal residual disease associate improved outcome adult precursor lymphoid neoplasm</brief_summary>
	<brief_title>Personalized Therapy Precursor Lymphoid Neoplasms</brief_title>
	<detailed_description>Between 1997-2010 PALG run three prospective study . In recent PLAG 5-2007 protocol attempt make individualize treatment . In particular , stratification high standard risk group base conventional clinical criterion level MRD induction consolidation . Patients unsatisfactory response refer allogeneic hematopoietic stem cell transplantation ( alloHSCT ) . Interim analysis show significant improvement compare previous PALG 4-2002 protocol regard overall survival leukemia-free survival . The reason failure relapse non-relapse mortality ( NRM ) associate alloHSCT . In current protocol intend adjust therapy individual patient need . We assume way able reduce risk relapse NRM improve cure rate . All patient receive multiagent induction consolidation chemotherapy . The type intensity therapy , well indication allogeneic autologous HSCT depend age , status MRD , immunophenotype presence BCR/ABL fusion gene .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm , Residual</mesh_term>
	<mesh_term>Lymphoma</mesh_term>
	<criteria>New diagnosis PLN accord WHO 2008 classification Age â‰¥18 year Biological status allow administration induction therapy Informed patient consent form sign Pregnancy Psychiatric diseases History malignancy HIV infection Active hepatitis Hypersensitivity drug use induction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Acute lymphoblastic leukemia</keyword>
	<keyword>Induction</keyword>
	<keyword>Consolidation</keyword>
	<keyword>Minimal residual disease</keyword>
	<keyword>Hematopoietic stem cell transplantation</keyword>
</DOC>